Back
Crinetics Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CRNX
Crinetics Pharmaceuticals
Last Price:
56.06
Seasonality Move:
7.41%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Crinetics Pharmaceuticals Price Quote
$56.06
-0.97 (-1.7%)
(Updated: November 22, 2024 at 5:55 PM ET)
Crinetics Pharmaceuticals Key Stats
Buy
56
Crinetics Pharmaceuticals (CRNX)
is a Buy
Day range:
$55.31 - $58.04
52-week range:
$29.72 - $62.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.35%
Volume:
681.4K
Avg. volume:
739K
1-year change:
90.48%
Market cap:
$5.3B
Revenue:
$4M
EPS:
$-3.73
How Much Does Crinetics Pharmaceuticals Make?
Data Unavailable
Is Crinetics Pharmaceuticals Growing As A Company?
Data Unavailable
Crinetics Pharmaceuticals Stock Price Performance
-
Did Crinetics Pharmaceuticals Stock Go Up Last Month?
Crinetics Pharmaceuticals share price went down by -2.85% last month -
Did CRNX's Share Price Rise Over The Last Year?
CRNX share price rose by 90.48% over the past 1 year
What Is Crinetics Pharmaceuticals 52-Week High & Low?
-
What Is Crinetics Pharmaceuticals’s 52-Week High Share Price?
Crinetics Pharmaceuticals has traded as high as $62.53 over the past 52 weeks -
What Is Crinetics Pharmaceuticals’s 52-Week Low Share Price?
Crinetics Pharmaceuticals has traded as low as $29.72 over the past 52 weeks
Crinetics Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Crinetics Pharmaceuticals?
-
How Much Debt Does Crinetics Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Crinetics Pharmaceuticals Have?
Cash and short term investments quarterly total is $862.7M -
What Is Crinetics Pharmaceuticals’s Book Value Per Share?
Book value per share is 10.30
Is Crinetics Pharmaceuticals Cash Flow Positive?
-
What Is CRNX Cash Flow From Operations?
Cash flow from operations (TTM) is -$199.8M -
What Is Crinetics Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $494.3M -
What Is Crinetics Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$120M
Crinetics Pharmaceuticals Return On Invested Capital
Data Unavailable
Crinetics Pharmaceuticals Earnings Date & Stock Price
-
What Is Crinetics Pharmaceuticals's Stock Price Today?
A single share of CRNX can be purchased today for 57.03 -
What Is Crinetics Pharmaceuticals’s Stock Symbol?
Crinetics Pharmaceuticals trades on the nasdaq under the ticker symbol: CRNX -
When Is Crinetics Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Crinetics Pharmaceuticals is scheduled on February 28, 2025 -
When Is CRNX's next ex-dividend date?
Crinetics Pharmaceuticals's next ex-dividend date is November 23, 2024 -
How To Buy Crinetics Pharmaceuticals Stock?
You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Crinetics Pharmaceuticals Competitors
-
Who Are Crinetics Pharmaceuticals's Competitors?
Below is a list of companies who compete with Crinetics Pharmaceuticals or are related in some way:
Crinetics Pharmaceuticals Dividend Yield
-
What Is CRNX Dividend Yield?
Crinetics Pharmaceuticals’s dividend yield currently is 0% -
What Is Crinetics Pharmaceuticals’s Payout Ratio?
Crinetics Pharmaceuticals’s payout ratio is 0% -
When Did Crinetics Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Crinetics Pharmaceuticals’s Dividend Per Share?
Crinetics Pharmaceuticals pays a dividend of $0.00 per share
Crinetics Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -5.38% |
| Revenue: | 0% | -100% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 73.29 |
| Upside from Last Price: | 28.5% |